Skip to main content

Indoco Remedies Share Price Live

221.41

-0.32(0.14%)

Live Indoco Remedies Share Price Chart

Indoco Remedies Performance

Days Range

Previous Close₹221.73
Open₹223
Volume88,655
Day's Range₹217.43 - ₹223.00
52W Range₹162.19 - ₹332.20
Market Cap₹2,045.45 Cr

Indoco Remedies Fundamentals

ROCE(TTM)0.77
P/E Ratio (TTM)651.76
P/B Ratio2.18
Industry P/E37.16
Debt to Equity1.16
ROE-10.13
EPS (TTM)N/A
Dividend Yield0.09
Book Value101.76
Face Value2
ROCE(TTM)0.77
P/E Ratio (TTM)651.76
P/B Ratio2.18
Industry P/E37.16
Debt to Equity1.16
ROE-10.13
EPS (TTM)N/A
Dividend Yield0.09
Book Value101.76
Face Value2

Indoco Remedies Financials

Sep 2025Dec 2025Mar 2026Jun 2026
Net Sales471.83434.34455.90466.22
Expenses473.87445.86458.39461.01
Profit before tax-13.53-31.31-25.0077.72
Operating Profit-9.21-29.45-23.6865.44
Net Profit-9.21-29.45-23.6865.44
EPS in Rs-0.94-2.53-2.98-3.46

Indoco Remedies Shareholding Pattern

Promoters
58.86%
Retail And Others
22.18%
Foreign Institutional Investors
1.27%
Domestic Institutional Investors
17.68%

About Indoco Remedies

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research. It also trades some active pharma ingredients (APIs) manufactured by a group company. Currently, Indoco has a presence in the therapeutic segments including anti-infective, anti-cold preparation, opthalmic, anti-spasmodic, stomatology, anti-inflammatory and anti-fungal. As per AC Nielsen ORG-MARG market survey (August 2004) of doctors, Indoco ranked first in the stomatology, ninth in the opthalmic and twelve in the pediatric segments in terms of prescription generation in the domestic market. In the overall pharma industry, Indoco is ranked 34th as per AC Nielsen ORG-MARG Retail Audit, but ranked 23rd in terms of prescription generation, indicating the strength of its marketing network. Further, the company last year launched a new super specialty division, with focus on diabetic and cardio-vascular segments. Its entry into the lifestyle segment with a strong presence in the prescription segment would augur well for the higher- than-average industry growth. Currently, Indoco has four manufacturing facilities. Two are located in Mumbai and two in Goa, and an R&D centre in Mumbai. The solid dosage facility in Goa has been accredited by UK-Medicines and Healthcare Products Regulatory Agency (MHRA), and the sterile plant of Goa has been designed as per US Food and Drug Administration (FDA) norms. On the selling front, it has a marketing network of 1,248 medical representatives.

Parent Organisation
Indian Private
Managing Director
Aditi Kare Panandikar
Founded
1947
NSE Symbol
INDOCO

Indoco Remedies Share Price History

ParticularsDetails
5-Year % change in Indoco Remedies share price4.04%
5-Year Highest in Indoco Remedies share price₹ 530.25
5-Year Lowest in Indoco Remedies share price₹ 190
1-Year % change in Indoco Remedies share price-28.4%
1-Year Highest in Indoco Remedies share price₹ 387.55
1-Year Lowest in Indoco Remedies share price₹ 190

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,948.0Price increase
3.00 (0.15%)
₹4,67,630.391,548.0 - 2,046.9
Divis Laboratories Ltd8,297.0Price increase
22.00 (0.27%)
₹2,18,971.765,636.5 - 8,585.0
Torrent Pharmaceuticals Ltd4,916.5Price decrease
-7.50 (-0.15%)
₹1,88,358.163,480.6 - 5,250.0
Cipla Ltd1,462.1Price decrease
-1.70 (-0.12%)
₹1,18,914.831,165.7 - 1,673.0
Zydus Lifesciences Ltd1,115.0Price increase
0.80 (0.07%)
₹1,11,241.63835.5 - 1,181.5
Lupin Ltd2,268.4Price decrease
-95.10 (-4.02%)
₹1,07,906.881,855.0 - 2,529.5

Indoco Remedies Ltd FAQs

Indoco Remedies Ltd (INDOCO) share price as of August 10, 2026, on NSE is Rs 221.41 (NSE) and Rs 221.41 (BSE) on BSE.
Yes, You can buy Indoco Remedies Ltd (INDOCO) shares by opening a Demat account with Angel One.
Indoco Remedies Ltd (INDOCO) share can be bought through the following modes:
1. Direct investment: You can buy Indoco Remedies Ltd (INDOCO) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Indoco Remedies Ltd (INDOCO) shares.
The main business of Indoco Remedies is manufacturing and marketing of Pharmaceutical formulations (i.e. finished dosages) and APIs (i.e. active pharmaceutical ingredients).
Spa Holdings Pvt Ltd, Shanteri Investment Pvt Ltd, Panandikar Aditi Milind, Ramani Madhura Anup, Kare Aruna Suresh and Kare Suresh Govind are some of the major promoters of Indoco Remedies.
As on March 31, 2022, the company has three subsidiary companies which are Xtend Industrial Designers and Engineers Private Limited, Indoco Remedies Czech SRO and Indoco Remedies UK. Limited.
The market cap of Indoco Remedies is Rs. 2045.45 Cr. as of 10/08/2026.
The P/E ratios of Indoco Remedies is 651.76 as of 10/08/2026.
The PB ratios of Indoco Remedies is 2.18 as of 10/08/2026.

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Top Losers

VIEW ALL

Open Free Demat Account!

Join our 3.5 Cr+ happy customers
+91